Increasing glycopolymer-based drug delivery success

Oct 19, 2012
Increasing glycopolymer-based drug delivery success
Credit: Thinkstock

Glycopolymer technology is opening up a myriad of new opportunities for disease therapy. European research is investigating novel production strategies for polymers to bring about more efficient targeted drug delivery.

Carbohydrates have been hailed as vital molecules in the human body. They are responsible for biological communication events involved in cellular recognition, inflammation and pathogen infection.

In the treatment of diseases, chemotherapy for example is normally not site-specific. To improve the location-finding ability of drugs to avoid unnecessary damage during therapy, (carbohydrates and peptides) for the recognition of could be a promising research avenue. Moreover, many studies have shown that lectins on cell-cell surfaces mediate interactions and result in better .

The ' conjugation of peptides/salmon calcitonin for increased efficacy' (Wbawba) project focused on the production of and characterisation of A-functional comb polymers by living radical polymerisation techniques. A second strand of the research involved synthesis of sugar-carrying polymers (glycopolymers) and their lectin-binding properties were then investigated.

Wbawba scientists developed a new rapid online polymerisation monitoring technique. In parallel, they used a rapid gel permeation chromatography (GPC) technique to follow copper (Cu)0-mediated polymerisation by monitoring molecular weight.

Optimisation of the conjugation of the and a peptide was achieved by a base-catalysed thiol-ene click reaction. Click chemistry joins together small units very rapidly and generates polymers extremely quickly. The optimum catalysts, reaction time and other required conditions were determined by this systematic structure-property relationship study.

The Wbawba project has also tested a small library of glycopolymers for their specific lectin recognition properties. These polymers show great promise for disease therapy and significantly inhibit the binding of dendritic cell lectins to the human immunodeficiency virus (HIV) isolated glycoprotein gp120, a step in the virus entry into the cell.

Future research planned by the Wbawba during and further to the life of the project will involve investigation of alternative synthesis techniques of glycopolymers that show improved binding to specific lectins.

Work of the Wbawba project has so far provided a basis for the development of glycopolymer-based disease therapies. Based on molecular recognition at the , the scientists have designed and efficiently produced glycopolymers that will target diseased cells specifically.

Explore further: Proteins: New class of materials discovered

add to favorites email to friend print save as pdf

Related Stories

Nanotube Coating Meshes with Living Cells

Aug 14, 2006

Using a polymer coating that mimics part of a cell’s outer membrane, a team of investigators at the University of California, Berkeley, have developed a versatile method for targeting carbon nanotubes to specific types ...

Clicking synthetic and biological molecules together

Feb 19, 2008

Dutch researcher Joost Opsteen has developed a method to click polymers together in a controlled manner. Using this method, he can even attach proteins to nanoballs. For instance, this approach could be used to transport ...

Recommended for you

Proteins: New class of materials discovered

Aug 22, 2014

Scientists at the Helmholtz Center Berlin along with researchers at China's Fudan University have characterized a new class of materials called protein crystalline frameworks.

The fluorescent fingerprint of plastics

Aug 21, 2014

LMU researchers have developed a new process which will greatly simplify the process of sorting plastics in recycling plants. The method enables automated identification of polymers, facilitating rapid separation ...

User comments : 0